T
Tenax Therapeutics, Inc. (TENX)
NCM – Real Time Price. Currency in USD
14.90
-0.07 (-0.47%)
At close: Mar 27, 2026, 4:00 PM EDT
14.90
0.00 (0.00%)
After-hours: Mar 27, 2026, 7:53 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
14.90
-0.07 (-0.47%)
At close: Mar 27, 2026, 4:00 PM EDT
14.90
0.00 (0.00%)
After-hours: Mar 27, 2026, 7:53 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 14.56 | 6.05 | 10 | |
| Quick ratio | 14.56 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -113K | -8K | N/A | N/A | N/A |
| Operating Income | -11M | -8M | -19M | -56M | -56M |
| Net Income | -11M | -8M | -18M | -53M | -53M |
| EBITDA | -11M | -8M | -19M | -56M | -56M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -41.67 | 1.0 |
| Next quarter | N/A | -54.32 | 1.0 |
| Current year | N/A | -16.17 | 1.0 |
| Next year | N/A | 6.08 | 3.0 |
| Weighted average score | 1.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 1.67 | 5 | -46.52 | 4.5 |
| Y/Y | 999 | -147.95 | -111.1 | -280.34 | 3.3 |
| 3y average | 999 | -98.95 | 58.32 | -80.56 | 5.5 |
| 5y average | 999 | -92.09 | 46.15 | -53.87 | 5.5 |
| Weighted average score | 4.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $97.6M barely cover the upcoming debt maturities $0.0
Total current assets $104.2M exceed Total current liabilities $7.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$13.4M limits the company's ability to reinvest or pay down debt